Company / Operating Cash Flow
ARDELYX, INC. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$42.5M
FY2025
5-year range
-$152.6M / -$42.5M
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
#92 of 216
Health Care
What the data says
At -$42M, ARDELYX, INC.'s operating cash flow ranks #92 of 216 in the Health Care sector. Operating Cash Flow has fluctuated over the past 10 years, ranging from -$153M in FY2021 to $13M in FY2016.
Based on SEC 10-K filings.
-$42M in FY2025.
Improved from -$90M to -$42M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#92 of 216 in Health CareTop 43% of 216This company -$42.5M Sector average $658.7M
▼
-106.4% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow increased 5.2% year-over-year.
- Ranks #92 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2016.
- Lowest operating cash flow in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$42.5M | +5.2% |
| FY2024 | -$44.8M | +50.1% |
| FY2023 | -$89.7M | -28.1% |
| FY2022 | -$70.0M | +54.1% |
| FY2021 | -$152.6M | -87.3% |
| FY2020 | -$81.4M | -6.5% |
| FY2019 | -$76.5M | -8.8% |
| FY2018 | -$70.3M | +2.2% |
| FY2017 | -$71.8M | -636.2% |
| FY2016 | $13.4M | +118.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026